John Crown - Researcher Profile | RDL Research Database

Publications

2 shown

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés , David W. Cescon , Hope S. Rugo +97 more

2020 The Lancet 1658 citations

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Gϋnter von Minckwitz , Chiun‐Sheng Huang , Max S. Mano +26 more

Among patients with HER2-positive early breast cancer who had residual invasive disease after completion of neoadjuvant therapy, the risk of recurrence of invasive breast cancer...

2018 New England Journal of Medicine 2430 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,088
Institution: Cancer Trials Ireland

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-3125-7613

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.